Latest / New Retina Radio by Eyetube
ARCHWAY at AAO
The Port Delivery System With Ranibizumab (Genentech) is under investigation for the treatment of wet AMD in the phase 3 ARCHWAY trial, data from which was shared at this year’s AAO Annual Meeting. Nancy Holekamp, MD, sits down with NRR to provide a primary analysis of the results of ARCHWAY and discusses safety outcomes.
This editorially independent podcast is supported with advertising.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.